Correlation Between Acrivon Therapeutics, and Granite Ridge

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Granite Ridge at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Granite Ridge into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Granite Ridge Resources, you can compare the effects of market volatilities on Acrivon Therapeutics, and Granite Ridge and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Granite Ridge. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Granite Ridge.

Diversification Opportunities for Acrivon Therapeutics, and Granite Ridge

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between Acrivon and Granite is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Granite Ridge Resources in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Granite Ridge Resources and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Granite Ridge. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Granite Ridge Resources has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Granite Ridge go up and down completely randomly.

Pair Corralation between Acrivon Therapeutics, and Granite Ridge

Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to under-perform the Granite Ridge. In addition to that, Acrivon Therapeutics, is 2.31 times more volatile than Granite Ridge Resources. It trades about -0.03 of its total potential returns per unit of risk. Granite Ridge Resources is currently generating about 0.29 per unit of volatility. If you would invest  570.00  in Granite Ridge Resources on September 2, 2024 and sell it today you would earn a total of  75.00  from holding Granite Ridge Resources or generate 13.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Acrivon Therapeutics, Common  vs.  Granite Ridge Resources

 Performance 
       Timeline  
Acrivon Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acrivon Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Acrivon Therapeutics, is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Granite Ridge Resources 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Granite Ridge Resources are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Granite Ridge may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Acrivon Therapeutics, and Granite Ridge Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Acrivon Therapeutics, and Granite Ridge

The main advantage of trading using opposite Acrivon Therapeutics, and Granite Ridge positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Granite Ridge can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Granite Ridge will offset losses from the drop in Granite Ridge's long position.
The idea behind Acrivon Therapeutics, Common and Granite Ridge Resources pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities